Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.02 USD
Change Today +0.02 / 0.67%
Volume 92.4K
ENZ On Other Exchanges
Symbol
Exchange
New York
Munich
As of 8:04 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew R. Crescenzo CPA

Former Senior Vice President of Finance, Enzo Biochem Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

59$243,696
As of Fiscal Year 2014

Background*

Andrew R. Crescenzo, CPA served as Senior Vice President of Finance at Enzo Biochem Inc. from May 2006 to May 2014. Mr. Crescenzo previously was an Executive Director with the international professional service and accounting firm of Grant Thornton LLP. Mr. Crescenzo started his tenure at Grant Thornton in February 1997 as a Senior Manager and for the past five years served as an Executive Director, managing a broad, diversified client base of public and privately owned ...

Read Full Background

Corporate Headquarters*

527 Madison Avenue
New York, New York 10022

United States

Phone: 212-583-0100
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
Adelphi University

Other Affiliations*

Annual Compensation*

Salary$193,423
Total Annual Compensation$193,423

Stock Options*

All Other Compensation$17,931
Unexercisable Options56,884
Total Number of Options56,884

Total Compensation*

Total Annual Cash Compensation$211,354
Total Short Term Compensation$193,423
Other Long Term Compensation$17,931
Total Calculated Compensation$243,696
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZ:US $3.02 USD +0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$536.9K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$735.3K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$767.9K
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$441.8K
Michael W. Hunkapiller Ph.D.Executive Chairman, Chief Executive Officer and President
Pacific Biosciences of California, Inc.
$1.00
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.